Mimi Healy, PhD – CEO
Dr. Healy has more than 20 years of healthcare, molecular diagnostics and biotechnology experience in both US and international markets. Dr. Healy pulls from a broad experience base having served roles in research and development, commercialization and executive management in both startup and established organizations in the past. Her experience includes all aspects of strategic development and implementation, corporate finance and fundraising, product development from research to the clinical validation and the successful market launch of molecular diagnostic systems and test kits. Her last position as President and CEO resulted in the successful financing of a start-up and its profitable exit via acquisition. Her product development skills have placed more than numerous commercial assays in the market. She serves on several grant review boards, has published in various scientific journals, authored several chapters and filed/received patents. Dr. Healy holds a Ph.D. in Microbiology, M.S. in Biology, B.S. in Biology with a minor in Chemistry, and B.A. in Psychology of Industry and Organizations.
David Hertzog, PhD – Vice President, Business Development
Dr. Hertzog joined LaserGen in 2008 after leaving the global management consulting firm McKinsey & Company where he led projects and managed client teams for several Fortune Global 10 companies in technology program planning, growth strategy, and product portfolio assessments. Prior to McKinsey, Dr. Hertzog developed microfluidic technologies for bioassay applications in the Biosecurity and Nanosciences Lab at Lawrence Livermore National Laboratory in Livermore, CA. Dr. Hertzog received his PhD at Stanford University in microfluidics, MS at Stanford University in aerospace engineering, and his BS at Cornell University in mechanical engineering.
Stacie Frye, PhD – Sr. Director of Commercialization
Dr. Frye has over 15 years of experience in the biotechnology industry. Through her positions at both start-up companies and large corporations, she has experience in technical sales & marketing, field support, regulatory, product development and commercialization. In her previous role of Director of Product Support and Marketing, she managed all aspects of the customer experience including management of a number of successful collaborations and evaluations with both domestic and international KOLs. As a part of software development projects, she worked as a knowledge engineer focused on integrating laboratory practices into software user interface and software testing. Dr. Frye holds a PhD in Chemical Engineering from Rice University and a BS in Chemical Engineering from New Mexico State University.
Weidong Wu, PhD – Director of Chemistry
Dr. Wu is an expert in synthetic organic chemistry with extensive experience in nucleic acids chemistry (heterocyclic bases, modified sugars, nucleosides, phosphoramidites, oligonucleotides, nucleotides), along with experience in phosphoro-organic chemistry, chemo-enzymatic synthesis and fluorescent dye labeling. He received his post-doctoral training at Purdue University and his PhD from Peking University. He has published over ten research papers in peer reviewed scientific journals and is co-inventor of multiple patents.
Kristy Reece – Operations Manager
Ms. Reece has over 10 years of experience in operations including manufacturing and commercialization, pilot production and scale-up. She has operated under a regulated environment, led medical device filings, established and implemented QA/QC processes, and managed both QA/QC and regulatory operations.